This can be addressed through fiber-rich breakfast choices
Maintenance dose: 25 mg orally once daily for cardiovascular risk reduction and weight reduction in adults
Clinical studies on weight loss suggest that people using tirzepatide can shed between 16% and 22% of their body weight, depending on the dosage
It must never be injected into a blood vessel or muscle
The translation of that indication is that cardiologists, endocrinologists, and primary care doctors may prescribe Ozempic to a patient with diabetes and known atherosclerotic disease even if their blood sugar is already well controlled
After stopping the medication, participants taking semaglutide regained 11.6% of their body weight, and those taking a placebo regained 1.9%, leading to a net weight loss of 5.6% in the semaglutide group and 0.1% in the placebo group